Captopril inhibits angiotensin-converting enzyme and it is the most used sub-lingual drug in emergency departments to decrease blood pressure. Sublingual captopril is safe, effective and useful in treating hypertensive urgency. However, it is known that captopril has fewer systemic and dermatologic side effects such as headache, weakness and oral ulcers, oral pemphigus, consecutively. No data is available about captopril induced oral mucositis. Herein, we present a 50-year-old hypertensive woman who uses sublingual captopril frequently and suffers from recurrent, reversible and painful oral mucositis that thought to be caused by sublingual captopril.
Birincil Dil | İngilizce |
---|---|
Konular | Sağlık Kurumları Yönetimi |
Bölüm | Case Report |
Yazarlar | |
Yayımlanma Tarihi | 10 Şubat 2020 |
Gönderilme Tarihi | 27 Ekim 2019 |
Kabul Tarihi | 18 Aralık 2019 |
Yayımlandığı Sayı | Yıl 2019 Cilt: 36 Sayı: 3 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.